# Revision of Requirements Applicable to Albumin (Human), Plasma Protein Fraction (Human), and Immune Globulin (Human)
> **Food and Drug Administration** · Final rule. · Published 2000-08-28 · Effective 2000-09-27 · 65 FR 52016
## Document
- **Document number:** 00-21897
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 52016
- **CFR reference:** 21 CFR 640
- **Publication date:** 2000-08-28
- **Effective date:** 2000-09-27
- **HHS docket:** Docket No. 98N-0608
## Abstract

The Food and Drug Administration (FDA) is amending the biologics regulations by removing, revising, or updating specific regulations applicable to blood derivative products to be more consistent with current practices and to remove unnecessary or outdated requirements. FDA is taking this action as part of the agency's "Blood Initiative" in which FDA is reviewing and revising, when appropriate, its regulations, policies, guidance, and procedures related to blood products, including blood derivatives.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/08/28/00-21897/revision-of-requirements-applicable-to-albumin-human-plasma-protein-fraction-human-and-immune)
---
*AI Analytics · CC0 1.0*